Focus on the R&D, production and sales of complex APIs and preparations, and CRO/CDMO of oligonucleotide drugs
Aurisco has been deeply involved in the pharmaceutical industry for more than 20 years and commits itself to continuous technological innovation. Today the company is playing a leading role in China in the field of complex synthesis, synthetic biology, photochemistry etc. And has become a long-term partner of the well-known pharmaceutical companies worldwide
Aurisco will attend CPHI Japan, April 19th to 21st, 2023,Tokyo, Japan. #booth at 5N-08 #
Aurisco will attend TIDES Asia, March 3rd to 7th, 2023, Kyoto, Japan.
Aurisco will attend DCAT Week 2023 20-23 March?2023. New York, USA
3
Manufacturing Facilities5
R & D Centers240+
Scientists400+
Partnerships1300+
Staff membersAurisco will attend CPHI Japan, April 19th to 21st, 2023,Tokyo, Japan. #booth at 5N-08 #
Aurisco will attend TIDES Asia, March 3rd to 7th, 2023, Kyoto, Japan.
Aurisco will attend DCAT Week 2023 20-23 March?2023. New York, USA
January 3,2023，Aurisco to build an Oligonucleotide FlexFactoryTM for commercial cGMP production in cooperation with Cytiva.
Aurisco will attend the 41st J.P. Morgan Healthcare Conference 9-12 Jan 2023 San Francisco,CA,USA
Aurisco will attend TIDES USA 2023 7 - 10 May 2023 San Diego, CA, USA
Aurisco will participate in RDD Europe 2023 in Nice, France
Aurisco will Exhibit at CPhI China 19-21 June?2023. Shanghai New International Expo Center.
Aurisco will participate in DDL 2022 in Edinburgh, UK, from December 7 to 9, 2022. Edinburgh International Conference Centre.
Aurisco will attend TIDES Europe 16 - 18 November?2022. Austria Center Vienna.
Aurisco is glad to announce our participance in CPHI Europe from Nov 1 to Nov 3. 2022. Aurisco 's entire team including our BD from US, EU is looking forward to meet our partners and friends , to present our new products , pipeline and CDMO service . Pls visit us at our booth (110H20, in hall no 11
We are going to attend DCAT week in New York City on March 21-24, 2022, let's meet soon !? Our meeting room location : Benjamin Hotel .
Shanghai Aurisco Biotechnology Co., Ltd. was Established
On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.
We will participate in CPHI China 2020 from Dec. 16 to Dec. 18, 2020 . Welcome to visit our booth W2C02, in hall W2.
We will participate in CPHI Japan from March 18 to March 20, 2019 . Welcome to visit our booth 2F-12
We will participate in CPHI Europe 2019 from November 5 to November 7, 2019 . Welcome to visit our booth 42G12, in hall 4.2.
We will participate in CPHI Europe 2018 in Madrid, Spain, from October 9 to October 11, ?2018 in Madrid, Spain. Welcome to visit our booth 10B10, in hall 10.
On September 21, 2020, Aurisco Pharmaceutical Co., Ltd. (Stock code: 605116) was officially listed on the Shanghai Stock Exchange. The per share issuing price is RMB 8.37 yuan, number of shares issued is 41 million shares, raising a capital of RMB 343 millions.
We will participate in CPHI China 2020 from Dec. 16 to Dec. 18, 2020 . Welcome to visit our booth W2C02, in hall W2.
We will participate in CPHI Japan from March 18 to March 20, 2019 . Welcome to visit our booth 2F-12
We will participate in CPHI Europe 2019 from November 5 to November 7, 2019 . Welcome to visit our booth 42G12, in hall 4.2.
We will participate in CPHI Europe 2018 in Madrid, Spain, from October 9 to October 11, ?2018 in Madrid, Spain. Welcome to visit our booth 10B10, in hall 10.
Follow Aoruite WeChat official account
